Cyanosis resident survival guide (pediatrics)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Usman Ali Akbar, M.B.B.S.[2]
Synonyms and keywords: Cyanosis approach in children, Cyanosis workup pediatrics, Cyanosis management in newborn, Approach to blue discoloration of skin in infants, Hypoxemia approach in children, Hypoxia approach in children
Cyanosis resident survival guide (pediatrics) Microchapters |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Overview
Cyanosis can be defined as bluish discoloration of skin and mucosa and can also be a manifestation of oxygen desaturation of arterial or capillary blood. Cyanosis, hypoxemia, and hypoxia should be differentiated and can occur independently. The causes of cyanosis in a newborn range from congenital cardiac conditions to life-threatening conditions such as exposure to toxic gases or infections leading to sepsis. The management of cyanosis depends upon the etiology and emergent cases with respiratory distress need rapid evaluation and response with immediate establishment of airway access and oxygen support.
Causes
Life-Threatening Causes | Pulmonary Causes | Congenital Cardiac Conditions | Hematological Causes | Peripheral Cyanosis |
---|---|---|---|---|
Decreased inspired FiO2
|
||||
Upper airway obstruction |
Pulmonary vascular disorders |
|||
Other Causes |
FIRE: Focused Initial Rapid Evaluation
Patients presenting to the emergency department with cyanosis and respiratory distress require emergency supplementation of O2, use of pulse-oximetry and airway, breathing, and circulation support.
- A Focused Initial Rapid Evaluation (FIRE) should be performed to identify the patients in need of immediate intervention.[3]
Patient present with cyanosis | |||||||||||||||||||||||||||||||||||||||||||||||
No Respiratory Distress | Respiratory Distress | ||||||||||||||||||||||||||||||||||||||||||||||
Peripheral Cyanosis | Central cyanosis | Differential Cyanosis | No Obstruction | Obstruction | |||||||||||||||||||||||||||||||||||||||||||
Reassurance & Warming | Hypoxia Test | Cardiac Evaulation | Hypoxia Test | Give O2 and Positive Pressure Ventilation | |||||||||||||||||||||||||||||||||||||||||||
PaO2<100 | PaO2 100-150 | PaO2 <100 | PaO2 100-150 | PaO2 >150 | ENT Evaluation | ||||||||||||||||||||||||||||||||||||||||||
Cardiac Evaluation | Persistent Pulmonary hypertension of newborn ,Cardiac Evaluation | Cardiac Cause | Persistent Pulmonary hypertension of newborn | Respiratory management, Give O2 and positive pressure Ventilation | |||||||||||||||||||||||||||||||||||||||||||
Complete Diagnostic Approach
Shown below is an algorithm summarizing the diagnosis of cyanosis in newborn according the the American Academy of Neonatology guidelines.
Patient presents with cyanosis | |||||||||||||||||
History
| |||||||||||||||||
Pysical Examination
| |||||||||||||||||
Diagnostic Studies
| |||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of cyanosis.[3][4]
Treatment Depends upon the etiology of cyanosis. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Respiratory Compromise | No Respiratory Compromise | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*An adequate airway should be established and supplemental oxygen is given.
| Depending upon etiology
Blood cultures should be obtained to identify the causative agent.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TGA, TAPVR ,Truncus arteriosus | TOF | Ebstein anomaly | Hypoplastic left heart syndrome | Sepsis, shock, low cardiac output state, cold exposure, metabolic disorder, polycythemia | Eisenmenger syndrome with pulmonary hypertension | Methemoglobinemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Infusion of Prostaglandin, Diuretic therapy,surgery [5] | Infusion of Prostaglandin for keeping patency of ductus arteriosus, infusion of vasodilator for reduced systemic resistance, mechanical ventilation in shock state and imposing hypercapnia and alveolar hypoxia for increased pulmonary resistance | Tricuspid valve repair[6] | Hypoplastic left heart syndrome | Treatment of underlying disorder | Phosphodiesterase-5 inhibitor (sildenafil, tadalafil), Endothelin receptor antagonist (bosentan,macitentan, ambrisentan)[7] | Infusion of Methylenblue,dextrose,N-acetyl cystein | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Hypoplastic left heart syndrome in infants should be considered with signs and symptoms such as sudden onset of shock , collapse and severe academia in the first week of life, as well as neonate sepsis and metabolic disorders.[8]
- In ebstein anomaly repair of tricuspid valve indicates if the following criteria is met :Cyanosis, Right-side heart failure, Poor functional capacity, Paradoxical emboli[6].
- In differential cyanosis if oxygen saturation of right arm is more than legs and improves with O2 supplemental therapy, think about severe coarctation of aorta, aortic arch interruption, primary pulmonary hypertension.
- In the presence of central cyanosis + hemolytic anemia (jaundice,heinze body,fragment RBC)+ renal failure consider about methemoglobinemia and treat accordingly.
- Hydration is important in Tetralogy of Fallot to maintain pulmonary blood flow through atretic pulmonary artery and reducing right to left shunt through VSD.[9]
- If paradoxical embolism is suspected and proceed with a Brain CT scan in the presence of new neurologic symptoms in cyanotic congenital heart disease because of passing the emboli from right to left shunt and hyperviscosity leading to thrombosis.[10]
Don'ts
- There are certain cyanotic congenital heart diseases that are dependent on patent ductus arteriosus(PDA). Don't give indomethacin to patients with the following ductal dependent congenital conditions.
- Hypoplastic left heart syndrome
- Critical Aortic stenosis
- Interrupted aortic arch
- Transposition of the great arteries
- Critical Pulmonary stenosis
References
- ↑ McMullen, SM; Patrick, W (2013). "Cyanosis". The American journal of medicine. 126 (3): 210–2. doi:10.1016/j.amjmed.2012.11.004. ISSN 0002-9343. PMID 23410559.
- ↑ Sasidharan, Ponthenkandath (2004). "An approach to diagnosis and management of cyanosis and tachypnea in term infants". Pediatric clinics of North America. Elsevier BV. 51 (4): 999–1021. doi:10.1016/j.pcl.2004.03.010. ISSN 0031-3955. PMID 15275985.
- ↑ 3.0 3.1 Dasgupta, Soham; Bhargava, Vidit; Huff, Monica; Jiwani, Amyn K.; Aly, Ashraf M. (2016-09-30). "Evaluation of The Cyanotic Newborn: Part I—A Neonatologist's Perspective". NeoReviews. American Academy of Pediatrics (AAP). 17 (10): e598–e604. doi:10.1542/neo.17-10-e598. ISSN 1526-9906.
- ↑ "Congenital Heart Disease". NCBI Bookshelf. 2010-07-22. Retrieved 2020-10-13.
- ↑ Rao, P. Syamasundar (2013). "Consensus on Timing of Intervention for Common Congenital Heart Diseases: Part II - Cyanotic Heart Defects". The Indian Journal of Pediatrics. 80 (8): 663–674. doi:10.1007/s12098-013-1039-2. ISSN 0019-5456.
- ↑ 6.0 6.1 Holst KA, Connolly HM, Dearani JA (2019). "Ebstein's Anomaly". Methodist Debakey Cardiovasc J. 15 (2): 138–144. doi:10.14797/mdcj-15-2-138. PMC 6668741 Check
|pmc=
value (help). PMID 31384377. - ↑ de Campos F, Benvenuti LA (2017). "Eisenmenger syndrome". Autops Case Rep. 7 (1): 5–7. doi:10.4322/acr.2017.006. PMC 5436914. PMID 28536680. Vancouver style error: initials (help)
- ↑ Gobergs R, Salputra E, Lubaua I (2016). "Hypoplastic left heart syndrome: a review". Acta Med Litu. 23 (2): 86–98. doi:10.6001/actamedica.v23i2.3325. PMC 5088741. PMID 28356795.
- ↑ O’Brien, Patricia; Marshall, Audrey C. (2014). "Tetralogy of Fallot". Circulation. 130 (4). doi:10.1161/CIRCULATIONAHA.113.005547. ISSN 0009-7322.
- ↑ . doi:10.1161/STROKEAHA.116.012882Stroke. Missing or empty
|title=
(help)